Cleared Traditional

K000687 - THE DAYA SYPHILIS TEST/THE TRUST ANTIGEN TEST

K000687 is an FDA 510(k) clearance for THE DAYA SYPHILIS TEST/THE TRUST ANTIGE..., manufactured by Beacon Biologicals, Inc.. The device is a Class 2 Microbiology device with product code GMQ cleared through the Traditional 510(k) pathway after a 104-day FDA review.

K000687 · Beacon Biologicals, Inc. · Microbiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 2000
Decision
104d
Days
Class 2
Risk

K000687 is an FDA 510(k) clearance for the THE DAYA SYPHILIS TEST/THE TRUST ANTIGEN TEST. Classified as Antigens, Nontreponemal, All (product code GMQ), Class II - Special Controls.

Submitted by Beacon Biologicals, Inc. (Boca Raton, US). The FDA issued a Cleared decision on June 12, 2000 after a review of 104 days - within the typical 510(k) review window.

This device falls under the Microbiology FDA review panel, regulated under 21 CFR 866.3820 - the FDA microbiology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Microbiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Beacon Biologicals, Inc. devices

FDA 510(k) Submission Details - K000687

510(k) Number K000687 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 29, 2000
Decision Date June 12, 2000
Days to Decision 104 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary Statement
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
2d slower than avg
Panel avg: 102d · This submission: 104d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GMQ Device Classification - Class 2, Special Controls

Product Code GMQ Antigens, Nontreponemal, All
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 866.3820
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Microbiology devices follow this clearance model.

Regulatory Peers - GMQ Antigens, Nontreponemal, All

All 22
Devices cleared under the same product code (GMQ) and FDA review panel - the closest regulatory comparables to K000687.
ASI Automated ASI RPR Test for Syphilis on the ASI Evolution
K182391 · Arlington Scientific, Inc. (Asi) · Nov 2018
ASI Evolution
K173376 · Arlington Scientific, Inc. (Asi) · Jun 2018
Gold Standard Diagnostics AIX1000 Rapid Plasma Reagin (RPR) Automated Test System
K150358 · Gold Standard Diagnostics · Nov 2015
SYNTHETIC VDRL ANTIGEN
K993633 · Centers For Disease Control and Prevention · Feb 2000
AVANTI POLAR LIPIDS VDRL ANTIGEN SLIDE TEST KIT WITH 10 X 0.5 ML AMPULES, AVANTI POLAR LIPIDS BULK BDRL ANTIGEN, AVANTI
K992124 · Avanti Polar Lipids, Inc. · Sep 1999
TRUST
K954994 · Guardian Scientific, Corp. · Oct 1996